Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Enhancing therapeutic efficacy by targeting non-oncogene addicted cells with combinations of signal transduction inhibitors and chemotherapy
Authors
Keywords
-
Journal
CELL CYCLE
Volume 9, Issue 9, Pages 1839-1846
Publisher
Informa UK Limited
Online
2010-05-21
DOI
10.4161/cc.9.9.11544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple p53-independent gene silencing mechanisms define the cellular response to p53 activation
- (2014) Ramiro París et al. CELL CYCLE
- BH3 activation blocks Hdmx suppression of apoptosis and cooperates with Nutlin to induce cell death
- (2011) Mark Wade et al. CELL CYCLE
- The insulin-like growth factor system as a potential therapeutic target in gastrointestinal stromal tumors
- (2011) Martin G. Belinsky et al. CELL CYCLE
- Stem cell aging: Survival of the laziest?
- (2011) Christa Muller-Sieburg et al. CELL CYCLE
- Phosphoinositide 3-kinase signaling overrides a G2phase arrest checkpoint and promotes aberrant cell cycling and death of hematopoietic cells after DNA damage
- (2011) Dipali Nimbalkar et al. CELL CYCLE
- Cancer stem cells and survival pathways
- (2011) Dolores Hambardzumyan et al. CELL CYCLE
- Resist or die: FOXO transcription factors determine the cellular response to chemotherapy
- (2011) Ana R. Gomes et al. CELL CYCLE
- Cancer and aging: More puzzles, more promises?
- (2011) Mikhail V Blagosklonny et al. CELL CYCLE
- Cancer stem cells: Models, mechanisms and implications for improved treatment
- (2011) Jiangbing Zhou et al. CELL CYCLE
- Deconstructing feedback-signaling networks to improve anticancer therapy with mTORC1 inhibitors
- (2011) Arkaitz Carracedo et al. CELL CYCLE
- Elevated MDM2 boosts the apoptotic activity of p53-MDM2 binding inhibitors by facilitating MDMX degradation
- (2011) Mingxuan Xia et al. CELL CYCLE
- The role of the PTEN/AKT Pathway in NOTCH1-induced leukemia
- (2011) Teresa Palomero et al. CELL CYCLE
- Perspective: Expanding role of cyclin dependent kinases in cytokine inducible gene expression
- (2011) Allan R. Brasier CELL CYCLE
- The p53 tumor suppressor protein is a critical regulator of hematopoietic stem cell behavior
- (2011) Yan Liu et al. CELL CYCLE
- Cancer stem cells and escape from drug-induced premature senescence in human lung tumor cells: Implications for drug resistance and in vitro drug screening models
- (2011) Michal Sabisz et al. CELL CYCLE
- DNA damage-induced cell death is enhanced by progression through mitosis
- (2011) Hanne Varmark et al. CELL CYCLE
- p38MAPK inhibitors attenuate cytokine production by bone marrow stromal cells and reduce stroma-mediated proliferation of acute lymphoblastic leukemia cells
- (2011) Shivashni S. Gaundar et al. CELL CYCLE
- Mutant p53 rescue and modulation of p53 redox state
- (2011) Vladimir J.N. Bykov et al. CELL CYCLE
- Pharmacologic inhibition of MEK and PI-3K converges on the mTOR/S6 pathway to decelerate cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- The transcription-independent mitochondrial p53 program is a major contributor to Nutlin-induced apoptosis in tumor cells
- (2011) Angelina V. Vaseva et al. CELL CYCLE
- Stem-cell driven cancer: "Hands-off" regulation of cancer development
- (2011) Carolina Vicente-Dueñas et al. CELL CYCLE
- Upregulation of the CDC25A phosphatase downstream of the NPM/ALK oncogene participates in anaplastic large cell lymphoma enhanced proliferation
- (2011) Anne Fernandez-Vidal et al. CELL CYCLE
- Aging-suppressants: Cellular senescence (hyperactivation) and its pharmacologic deceleration
- (2011) Mikhail V Blagosklonny CELL CYCLE
- The CML stem cell: Evolution of the progenitor
- (2011) Scott A. Stuart et al. CELL CYCLE
- At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Rapamycin decelerates cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Genomic instability en route to and from cancer stem cells
- (2011) Linda Li et al. CELL CYCLE
- Targeting mTOR with rapamycin: One dose does not fit all
- (2011) David A. Foster et al. CELL CYCLE
- PIK3CA mutations in human solid tumors: Role in sensitivity to various therapeutic approaches
- (2011) Giovanni Ligresti et al. CELL CYCLE
- Chronic inflammation, the tumor microenvironment and carcinogenesis
- (2011) Tamas A. Gonda et al. CELL CYCLE
- Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance
- (2011) Ayesha B. Alvero et al. CELL CYCLE
- PI3K/mTORC1 activation in hamartoma syndromes: Therapeutic prospects
- (2011) Vera P. Krymskaya et al. CELL CYCLE
- Dominant roles of the Raf/MEK/ERK pathway in cell cycle progression, prevention of apoptosis and sensitivity to chemotherapeutic drugs
- (2011) Linda S. Steelman et al. CELL CYCLE
- Growth stimulation leads to cellular senescence when the cell cycle is blocked
- (2010) Zoya N. Demidenko et al. CELL CYCLE
- Targeting prostate cancer based on signal transduction and cell cycle pathways
- (2010) John T. Lee et al. CELL CYCLE
- RHAMM is differentially expressed in the cell cycle and downregulated by the tumor suppressor p53
- (2010) Sindy Sohr et al. CELL CYCLE
- The c-Jun N-terminal kinase JNK functions upstream of Aurora B to promote entry into mitosis
- (2010) Kutluk Oktay et al. CELL CYCLE
- Aging: ROS or TOR
- (2010) Mikhail V Blagosklonny CELL CYCLE
- Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK
- (2010) Alina Felicia Nica et al. CELL CYCLE
- Basal c-Jun N-terminal kinases promote mitotic progression through histone H3 phosphorylation
- (2010) Kyunghee Lee et al. CELL CYCLE
- Enhancement of cancer chemotherapy by simultaneously altering cell cycle progression and DNA-damage defenses through global modification of the serine/threonine phospho-proteome
- (2010) Zhengping Zhuang et al. CELL CYCLE
- Specific activation of the p53 pathway by low dose actinomycin D: A new route to p53 based cyclotherapy
- (2010) Meng Ling Choong et al. CELL CYCLE
- Defining pathways that enforce cell lineage specification in early development and stem cells
- (2010) Stephen Roper et al. CELL CYCLE
- The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy
- (2010) Stephen L. Abrams et al. CELL CYCLE
- Emerging MEK inhibitors
- (2010) James A McCubrey et al. EXPERT OPINION ON EMERGING DRUGS
- Dual Inhibition of Class IA Phosphatidylinositol 3-Kinase and Mammalian Target of Rapamycin as a New Therapeutic Option for T-Cell Acute Lymphoblastic Leukemia
- (2009) F. Chiarini et al. CANCER RESEARCH
- A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal
- (2009) Federica Catalanotti et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Early Phosphatidylinositol 3-Kinase/Akt Pathway Activation Limits Poliovirus-Induced JNK-Mediated Cell Death
- (2008) A. Autret et al. JOURNAL OF VIROLOGY
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia
- (2008) E D Lagadinou et al. LEUKEMIA
- The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism
- (2008) F Chiarini et al. LEUKEMIA
- Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance
- (2008) J A McCubrey et al. LEUKEMIA
- Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
- (2008) N Misaghian et al. LEUKEMIA
- Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways to leukemia
- (2008) L S Steelman et al. LEUKEMIA
- Suppression of PTEN function increases breast cancer chemotherapeutic drug resistance while conferring sensitivity to mTOR inhibitors
- (2008) L S Steelman et al. ONCOGENE
- Aging, Stem Cells, and Mammalian Target of Rapamycin: A Prospect of Pharmacologic Rejuvenation of Aging Stem Cells
- (2008) Mikhail V. Blagosklonny REJUVENATION RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now